HMGB1 and Duchenne muscular dystrophy: To assess whether HMGB1 or VCAM1 protein content could serve as a diagnostic and/or surrogate biomarker in DMD skeletal muscle, cells were treated with AAV microdystrophin (Fig. 3A).